- Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories | Start Date 01-12-2003 | End Date |
Previous Name | Previous Name Zinc oxide 283.5mg / Lignocaine 13.2mg suppositories | Start Date 12-02-2003 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- suppository
- Unit Dose UOM
- suppository
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Rectal
- Form
- Suppository
- Ontology Form/Route
- suppository.rectal
- Name Basis
- Other
Codes
- ATC Code
- C05AX04
BNF | Start Date | End Date |
---|---|---|
Current BNF 01070100 | Start Date 04-04-2022 | End Date |
Previous BNF 01070100 | Start Date 04-02-2005 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
3876111000001102 | 12-02-2003 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Lidocaine hydrochloride | Based on Ingredient Substance | 13.2 mg | ||
Zinc oxide | Based on Ingredient Substance | 283.5 mg |
Name
Zinc oxide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
283.5
Strength and UOM (Dmr)
Name
Lidocaine hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
13.2
Strength and UOM (Dmr)
Parent Products
-
VTMZinc oxide + Lidocaine
-
VMP(Current) Zinc oxide 283.5mg / Lidocaine 13.2m...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
12 suppository | 339 | Part VIIIA Category C |
24 suppository | 566 | Part VIIIA Category C |